Stock-Based Compensation - SAR Activity (Detail) - Stock Appreciation Rights (SARs) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule Of Stock Appreciation Rights Activity [Line Items]
SARs Outstanding, Beginning Balance	219,880	233,969	200,998
Granted, SARs	33,277	51,916	32,971
Exercised, SARs	(58,767)	(53,036)	0
Canceled, SARs	(4,142)	(12,969)	0
Shares Outstanding, SARs, Ending Balance	190,248	219,880	233,969
Vested, SARs	122,598
Exercisable, SARs	122,598
Outstanding, Weighted Average Grant Price Per Share, Beginning Balance	$ 49.34	$ 40.64	$ 33.86
Granted, Weighted Average Grant Price Per Share	90.86	56.8	82.01
Exercised, Weighted Average Grant Price Per Share	35.77	11.95	0
Canceled, Weighted Average Grant Price Per Share	89.99	75.25	0
Outstanding, Weighted Average Grant Price Per Share, Ending Balance	59.91	$ 49.34	$ 40.64
Vested, Weighted Average Grant Price Per Share	51.41
Exercisable, Weighted Average Grant Price Per Share	$ 51.41
Weighted Average Remaining Contractual Life, Outstanding	6 years 3 months 18 days
Weighted Average Remaining Contractual Life, Vested	5 years 1 month 6 days
Weighted Average Remaining Contractual Life, Exercisable	5 years 1 month 6 days
Aggregate Intrinsic Value, Outstanding	$ 3,145,845
Aggregate Intrinsic Value, Vested	2,794,991
Aggregate Intrinsic Value, Exercisable	$ 2,794,991